Health & WellnessTech
ViiT Health
Non-Invasive Painless Glucometer Monitors Blood Sugar Levels With Top Accuracy
Delaware City,
DE
Investment type:
Equity
(SAFE)
Target raise:
$50,000
- $2,000,000
Minimum investment:
$100
$100
End date:
Feb 18, 2022
Feb 18, 2022
ended
Share
Highlights
- Immediate disruption of the global invasive glucometer market estimated at $+10B USD.
- Background Dev company raised $+2M for R&D by leading private and public investors.
- Twice selected for funding by the Mexican National Council for Science and Technology.
- Massive potential market of 422M diabetics worldwide, and 88M prediabetics in the U.S. alone.
Our Story
ViiT Health enables access to health through computer vision. We create algorithms based on visual recognition and use them to classify patterns for health monitoring. Our non invasive glucose measurement device can achieve results in real time, with greater assertiveness than puncture glucometers, by efficiently processing images of in vivo tissue and correlating them to high and low values of glucose levels using artificial intelligence.
Our Ambition
We wish to have assisted in lowering the cases of type I and II diabetes around the world by placing our device within many prevention campaigns and distributing it to hospitals, clinics and pharmacies. We also envision that in the following 5 years our technology will be capable of measuring different kinds of analytes such as triglycerides, cholesterol and lactate concentrations, not to mention that our glucometer device could also determine the levels of oxygen in blood.